Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Status: Enrolling
Updated:  2/3/2011
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Status: Enrolling
Updated: 2/3/2011
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Treatment of Residual Diabetic Macular Edema With Ranibizumab
Open Label, Phase I/II, Residual Edema Evaluation With 0.5mg and 2.0mg Ranibizumab Formulations (REEF)
Status: Enrolling
Updated:  2/9/2011
California Retina Consultants
1983
mi
from 43215
Bakersfield, CA
Treatment of Residual Diabetic Macular Edema With Ranibizumab
Open Label, Phase I/II, Residual Edema Evaluation With 0.5mg and 2.0mg Ranibizumab Formulations (REEF)
Status: Enrolling
Updated: 2/9/2011
California Retina Consultants
1983
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
Treatment of Residual Diabetic Macular Edema With Ranibizumab
Open Label, Phase I/II, Residual Edema Evaluation With 0.5mg and 2.0mg Ranibizumab Formulations (REEF)
Status: Enrolling
Updated:  2/9/2011
Retina Institute of Hawai'i
4501
mi
from 43215
Honolulu, HI
Treatment of Residual Diabetic Macular Edema With Ranibizumab
Open Label, Phase I/II, Residual Edema Evaluation With 0.5mg and 2.0mg Ranibizumab Formulations (REEF)
Status: Enrolling
Updated: 2/9/2011
Retina Institute of Hawai'i
4501
mi
from 43215
Honolulu, HI
Click here to add this to my saved trials
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated:  2/13/2011
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated: 2/13/2011
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated:  2/13/2011
Oregon Heart and Vascular Institute
2052
mi
from 43215
Springfield, OR
Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease
Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease
Status: Enrolling
Updated: 2/13/2011
Oregon Heart and Vascular Institute
2052
mi
from 43215
Springfield, OR
Click here to add this to my saved trials
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes
Pilot and Feasibility Study for a Pharmacogenomic Trial in Type 1 Diabetes
Status: Enrolling
Updated:  2/17/2011
University of Pittsburgh Diabetes and Lipid Research Clinic
165
mi
from 43215
Pittsburgh, PA
Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes
Pilot and Feasibility Study for a Pharmacogenomic Trial in Type 1 Diabetes
Status: Enrolling
Updated: 2/17/2011
University of Pittsburgh Diabetes and Lipid Research Clinic
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
Status: Enrolling
Updated:  2/22/2011
Drexel University College of Medicine/St. Christopher's Hospital for Children
416
mi
from 43215
Philadelphia, PA
Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
Real-time 3-Dimensional Echocardiography for Assessment of Cardiac Function and Congenital Heart Disease
Status: Enrolling
Updated: 2/22/2011
Drexel University College of Medicine/St. Christopher's Hospital for Children
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated:  2/24/2011
Atlanta Heart Specialist, LLC
402
mi
from 43215
Cumming, GA
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated: 2/24/2011
Atlanta Heart Specialist, LLC
402
mi
from 43215
Cumming, GA
Click here to add this to my saved trials
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated:  2/24/2011
Atlanta Heart Specialists, LLC
427
mi
from 43215
Tucker, GA
Ranolazine, Ethnicity and the Metabolic Syndrome
Ranolazine, Ethnicity and the Metabolic Syndrome - REMS Study
Status: Enrolling
Updated: 2/24/2011
Atlanta Heart Specialists, LLC
427
mi
from 43215
Tucker, GA
Click here to add this to my saved trials
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
Assessment of Subclinical Atherosclerosis in Healthy Adult Immigrant Asian Indians Using Flow Mediated Endothelial Dysfunction Method
Status: Enrolling
Updated:  3/1/2011
Long Island Jewish Medical Center
494
mi
from 43215
New Hyde Park, NY
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
Assessment of Subclinical Atherosclerosis in Healthy Adult Immigrant Asian Indians Using Flow Mediated Endothelial Dysfunction Method
Status: Enrolling
Updated: 3/1/2011
Long Island Jewish Medical Center
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
Computed Tomographic Perfusion and Computed Tomographic Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated:  3/2/2011
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
Computed Tomographic Perfusion and Computed Tomographic Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
Status: Enrolling
Updated: 3/2/2011
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Predicting Hypotension During Dialysis in the ICU
Predicting Hypotension During Dialysis in the ICU
Status: Enrolling
Updated:  3/3/2011
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Predicting Hypotension During Dialysis in the ICU
Predicting Hypotension During Dialysis in the ICU
Status: Enrolling
Updated: 3/3/2011
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
Status: Enrolling
Updated:  3/9/2011
Illinois Fire Service Institute
276
mi
from 43215
Champaign, IL
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
Status: Enrolling
Updated: 3/9/2011
Illinois Fire Service Institute
276
mi
from 43215
Champaign, IL
Click here to add this to my saved trials
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Status: Enrolling
Updated:  3/18/2011
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation
Status: Enrolling
Updated: 3/18/2011
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
The Hartford Hospital
554
mi
from 43215
Hartford, CT
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
The Hartford Hospital
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Shawnee Mission
624
mi
from 43215
Shawnee Mission, KA
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Shawnee Mission
624
mi
from 43215
Shawnee Mission, KA
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Valley Hospital
470
mi
from 43215
Hawthorne, NJ
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Valley Hospital
470
mi
from 43215
Hawthorne, NJ
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Ohio State University
2
mi
from 43215
Columbus, OH
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Riverside Methodist
1
mi
from 43215
Columbus, OH
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Riverside Methodist
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Pinnacle Health
323
mi
from 43215
Wormleysburg, PA
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Pinnacle Health
323
mi
from 43215
Wormleysburg, PA
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
York Hospital
332
mi
from 43215
York, PA
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
York Hospital
332
mi
from 43215
York, PA
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Methodist Hospital
995
mi
from 43215
Houston, TX
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Methodist Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated:  3/18/2011
Intermountain Medical Center
1515
mi
from 43215
Murray, UT
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Status: Enrolling
Updated: 3/18/2011
Intermountain Medical Center
1515
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift
A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift
Status: Enrolling
Updated:  3/19/2011
Davis B Nguyen, M.D.
1980
mi
from 43215
Beverly Hills, CA
Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift
A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift
Status: Enrolling
Updated: 3/19/2011
Davis B Nguyen, M.D.
1980
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies
TRIAL OF COMPASSIONATE USE OF HP802-247 TO TREAT VENOUS LEG ULCERS IN SUBJECTS WHO HAVE FAILED MULTIPLE OTHER HEALING TECHNOLOGIES
Status: Enrolling
Updated:  3/21/2011
Overlook Hospital Wound Healing Program
458
mi
from 43215
Summit, NJ
Trial of Compassionate Use of hp802-247 to Treat Venous Leg Ulcers in Subjects Who Have Failed Multiple Other Healing Technologies
TRIAL OF COMPASSIONATE USE OF HP802-247 TO TREAT VENOUS LEG ULCERS IN SUBJECTS WHO HAVE FAILED MULTIPLE OTHER HEALING TECHNOLOGIES
Status: Enrolling
Updated: 3/21/2011
Overlook Hospital Wound Healing Program
458
mi
from 43215
Summit, NJ
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
3103
mi
from 43215
Anchorage, AK
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
3103
mi
from 43215
Anchorage, AK
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1653
mi
from 43215
Scottsdale, AZ
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1653
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1969
mi
from 43215
Bakersville, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1969
mi
from 43215
Bakersville, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1949
mi
from 43215
Chula Vista, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1949
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1969
mi
from 43215
Downey, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1969
mi
from 43215
Downey, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
2098
mi
from 43215
East Palo Alto, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
2098
mi
from 43215
East Palo Alto, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
2090
mi
from 43215
Salinas, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
2090
mi
from 43215
Salinas, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1983
mi
from 43215
Torrance, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1983
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1981
mi
from 43215
Van Nuys, CA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1981
mi
from 43215
Van Nuys, CA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1161
mi
from 43215
Colorado Springs, CO
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1161
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
1162
mi
from 43215
Denver, CO
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
328
mi
from 43215
Washington,
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
830
mi
from 43215
Clearwater, FL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
830
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
832
mi
from 43215
Melbourne, FL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
832
mi
from 43215
Melbourne, FL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
747
mi
from 43215
Ocala, FL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
747
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
933
mi
from 43215
Wellington, FL
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
933
mi
from 43215
Wellington, FL
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
529
mi
from 43215
Columbus, GA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
529
mi
from 43215
Columbus, GA
Click here to add this to my saved trials